Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy InMode stock | $171.05

Learn how to easily invest in InMode stock.

InMode Ltd is a medical devices business based in the US. InMode shares (INMD) are listed on the NASDAQ and all prices are listed in US Dollars. InMode employs 311 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in InMode

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – INMD – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

InMode stock price (NASDAQ: INMD)

Use our graph to track the performance of INMD stocks over time.

InMode shares at a glance

Information last updated 2021-09-18.
Latest market close$171.05
52-week range$33.92 - $146.73
50-day moving average $121.98
200-day moving average $94.48
Wall St. target price$123.80
PE ratio 47.6998
Dividend yield N/A (0%)
Earnings per share (TTM) $2.99

Buy InMode shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
0%
N/A
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Sofi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
TradeStation
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$50
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Public
Stocks, ETFs
N/A
$0 per month
Download and sign up with Public.com; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy InMode stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

InMode price performance over time

Historical closes compared with the close of $171.05 from 2021-09-23

1 week (2021-09-17) 19.89%
1 month (2021-08-25) 37.80%
3 months (2021-06-25) 76.92%
6 months (2021-03-25) 152.66%
1 year (2020-09-25) 373.95%
2 years (2019-09-25) 533.05%
3 years (2018-09-21) N/A
5 years (2016-09-21) N/A

Is InMode under- or over-valued?

Valuing InMode stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of InMode's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

InMode's P/E ratio

InMode's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 48x. In other words, InMode shares trade at around 48x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

InMode's PEG ratio

InMode's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.3325. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into InMode's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

InMode's EBITDA

InMode's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $127.5 million.

The EBITDA is a measure of a InMode's overall financial performance and is widely used to measure a its profitability.

InMode financials

Revenue TTM $287.8 million
Operating margin TTM 44.15%
Gross profit TTM $175.3 million
Return on assets TTM 25.57%
Return on equity TTM 47.59%
Profit margin 44.34%
Book value $8.11
Market capitalisation $5.4 billion

TTM: trailing 12 months

Shorting InMode shares

There are currently 1.9 million InMode shares held short by investors – that's known as InMode's "short interest". This figure is 12% down from 2.2 million last month.

There are a few different ways that this level of interest in shorting InMode shares can be evaluated.

InMode's "short interest ratio" (SIR)

InMode's "short interest ratio" (SIR) is the quantity of InMode shares currently shorted divided by the average quantity of InMode shares traded daily (recently around 792706.69456067). InMode's SIR currently stands at 2.39. In other words for every 100,000 InMode shares traded daily on the market, roughly 2390 shares are currently held short.

However InMode's short interest can also be evaluated against the total number of InMode shares, or, against the total number of tradable InMode shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case InMode's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 InMode shares in existence, roughly 40 shares are currently held short) or 0.0586% of the tradable shares (for every 100,000 tradable InMode shares, roughly 59 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against InMode.

Find out more about how you can short InMode stock.

InMode share dividends

We're not expecting InMode to pay a dividend over the next 12 months.

InMode share price volatility

Over the last 12 months, InMode's shares have ranged in value from as little as $33.92 up to $146.7325. A popular way to gauge a stock's volatility is its "beta".

INMD.US volatility(beta: 1.88)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while InMode's is 1.8793. This would suggest that InMode's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

InMode overview

InMode Ltd. designs, develops, manufactures, and markets minimally-invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies. The company offers minimally-invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. InMode Ltd. offers its products directly in United States, Canada, United Kingdom, Spain, India, Australia, and France, as well as through distributors in 47 countries. The company was formerly known as Invasix Ltd.

Frequently asked questions

What percentage of InMode is owned by insiders or institutions?
Currently 35.221% of InMode shares are held by insiders and 64.057% by institutions.
How many people work for InMode?
Latest data suggests 311 work at InMode.
When does the fiscal year end for InMode?
InMode's fiscal year ends in December.
Where is InMode based?
InMode's address is: Tavor Building, Yokne'am, Israel, 2069206
What is InMode's ISIN number?
InMode's international securities identification number is: IL0011595993
What is InMode's CUSIP number?
InMode's Committee on Uniform Securities Identification Procedures number is: 45810N302

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site